EMA Initiates DARWIN EU Coordination Centre
EMA has started the establishment of its Data Analysis and Real World Interrogation Network (DARWIN EU) Coordination Centre.
The European Medicines Agency (EMA) has revealed that it has started the establishment of its Data Analysis and Real World Interrogation Network (DARWIN EU) Coordination Centre, in a Feb. 9, 2022 press release.
The DARWIN EU Coordination Centre is aimed at the development and management of real-world healthcare data sources across the European Union (EU). Additionally, the center will be used to conduct scientific studies that are requested by medicines regulators and, later on, those that have been requested by other stakeholders.
It is hoped that the center will provide EMA and other national competent authorities in the region with access to valid and trustworthy real-world evidence. Many stakeholders are expected to benefit through this resource, which will support decision-making on the development, authorization, and surveillance of medicines. Furthermore, EMA expects that the center will be an invaluable resource for the preparation and response to future healthcare crises and pandemics.
The Erasmus University Medical Center Rotterdam will be working with EMA as a contractor on the establishment of the DARWIN EU Coordination Centre. More information is available on EMA’s website.
Source: EMA
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
AES Clean Technology Launches Next-Generation OSM Utility Solution for Cleanrooms at INTERPHEX 2025
April 2nd 2025Officially launched at INTERPHEX 2025, the Omni ASCENT is a next-generation off-site manufactured vertical utility solution that offers optimized cleanroom flexibility and efficiency.
